Sanidad approves this year as its precision medicine strategy, the ‘traje a medida’ para numerosas enfermedades rar …

Pasar de ‘talla unica’ al ‘traje a medida’. This is the objective that pursues the new Strategic Medicine Plan Personalized Precision that refers to the Health Care Council and supports a change in the prevention and treatment of number of patients and patients who are distinguished by their genetics, their susceptibility to pathology to respond to a determined treatment.

The strategy, which is being worked on for the light of this year 2021 and which will be implanted in a progressive manner, will affect both patients who have rare diseases, such as oncological processes and other hereditary diseases, according to the Sanitary Council.

The planning is based on a new vision of medicine, a paradigm shift that is being carried out in a more precise clinical setting, as well as in diagnostic treatment, which is adjusted to a single patient, which will be returned to the best of quality, reduce adverse effects and advance in safety.

With these conditions, and in the manner of the “vertiginoso advancement of technology”, the plan will include 13 strategic lines that include the development of the service map and resource map; parameters to ensure the compliment of the estates; implement technology for the diagnosis of genetic bases, while incorporating new specialties into the system such as Clinical Genetics or Bioinformatics.

Objectives also pass by the compliment of ethical standards, information maneuver on a large scale; study of the variability of the response to pharmacies, and aspects related to the cooperation, the coordination of professionals and the training.

The document will be included in the investigation, which will also be compared with a plan related to the incorporation of new specialists, including training strategies, as well as continuing education, as well as other research and innovation measures in the ambitious data a Pharmacogenetics application.

“The personalized medicine of precision centers the attention to the individual characteristics of the patient. Aunar las ventajas de la technology with the personalization of the assistance allows to center more sanitary attention and adapt in each case “, explains to Ical the head of the Regional Reference Unit of Raras de Castilla y León, DiERCyL, María Isidoro Garc que also is the service of the Clinical Analysis Service of the Salamanca University Assistant Center.

Reference model

The doctor points out the opportunities for patients over the strategy, based on the “new vision that has developed in Castile and Leon in the long run of the last years, which has been a pioneer in many camps of the genome of genetics or Pharmacogenetics ”, precise.

Hecho, explains that the Informe del Instituto Roche ‘Personalized medicine in Spain: map of communities’ of 2019, located in Castilla y León between the communities with the mayor of Desarroll, together with Andalusia, Catalonia, Galicia and the Netherlands concludes that “the methodology defined for the application of the personalized precision medicine in Castile and Leon is considered as a reference level of state-level implantation potential in other autonomous communities”. Professional professionals from all over Spain have joined the Community to announce their model, which has more than thirty years of list of aspirations.

Opportunities

What is being done is that the system is moving towards the patient, in such a way that it also facilitates the continuity of assistance, reduces the number of appointments between the distant consultations and the times of response, adjusts the clinical diagnostic resources and the laboratories to the nec in each case, avoid duplication and facilitate the creation of multidisciplinary teams with a mayor coordination and communication between specialists in the clinical evaluation of patients, says Isidoro García.

The planning is part of the premise of the extension and geographical dispersion of Castile and Leon for which it is necessary to coordinate and approve the resources as much as possible. Also, given the difficulties that plant the enormous technological-genomic development and massive sequencing, determination of biomarkers, use of large volumes of data, among others – that obliges Sacyl to incorporate the ultimate advances. Hecho, shows the need for a specialized lift by professionals, both in clinical practice as in the laboratory.

First steps

At the moment, Castilla y León has a variety of plans and services to build its new strategy and amplify it. It is the case of the hereditary cancer program, especially in breast, ovarian and colon cancer; the CSUR National Reference Unit for Family Cardiopathies, in Salamanca, which has a high level of specialized specialization, among other aspects, in the prevention of homicidal death; and the Regional Unit for Regional Diagnostic Advancement of Rare Nurses, which currently has 2,500 patients from all over the Community, with the identification of more than 50 ultra-rare patients.

También, there is the Prenatal Diagnostic Unit in Invasive, recently accredited, and the Unit of Pharmacogenetics and Precision Medicine, in Salamanca, pioneered the application of pharmacogenetic studies in the treatment of polymathic patients; the use of biomarkers for the selection of treatment for tumor determination; and the development of therapies CART-t developed in the hospital charro ante some hematologic cancers.

These are the ultimate therapies that demonstrate the characteristics and realities of precision medicine. If human cells – linocytes T – are extracted from the proprietary patient that is genetically modified, administers new to the patient and allows these linocytes T to recognize a specific protein, an antigen, from the tumor cells.

“The strategy of planting new scenarios related to the assistance coordination, which can facilitate the access of our patients to the distant assistance structures as well as the implementation of units that can have more need to develop” is the result of the conclusion Genomics of Precision, which will be rolled out in the Senado in 2019 and on which the national planning is maintained. “The autonomous strategy takes into account all the aspects of its conclusions and our position in order to be able to unravel each of the aspects, for which we will be completely detached”, sentence.

Source